Atlas Trials

A 12-month Real Life Study of IBD Patients Switched From Adalimumab Originator Humira® to One of Its Biosimilar

Clinical trial NCT04422171 · UNKNOWN

Trial details

NCT number
NCT04422171
Sponsor
University Hospital, Grenoble
Status
UNKNOWN
Study type
OBSERVATIONAL
IBD Patients, Originator Treatment, Biosimilar, Switch Back
Start date
2020-06-19
Primary completion
2021-06-18
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.